Thursday, January 21, 2016

$1.4 billion ...


... in additional rebates for generic drugs would have been received by Medicaid under its rebate program if the calculation for generic drugs contained an inflationary factor like the one that is applied to brand-name drugs, according to a new analysis by the HHS Office of Inspector General.

No comments:

Post a Comment